List view / Grid view
21 March 2019 | By Eurofins CDMO
Eurofins CDMO provides full range of drug development and manufacturing services from formulation screening and development, analytical development, stability studies and pre-clinical safety assessment studies to sterile and non-sterile manufacturing, IND/ IMPD and NDA/ CTD services, as well as clinical trial material including packaging and logistics.
8 March 2019 | By Particle Measuring Systems
The Italian Biochemical Institute, Comecer, and Particle Measuring Systems share expertise to develop and manufacture a safer intravenous solution...
7 March 2019 | By Dr Holger Kranenburg - containment lead at Franz Ziel GmbH, James L. Drinkwater - Head of GMP Compliance at F Ziel GmbH
Active pharmaceutical ingredients (APIs) have been established in the pharmaceutical industry over the course of many years. Containment technologies – ie, those strategies developed to contain the APIs – and qualification practices based on API powder containment have primarily been based on health and safety issues related to operator exposure…
22 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
The European Medicines Agency (EMA) has lost a High Court case, meaning it will have to pay the remaining 20 years left on the lease...
21 February 2019 | By Telstar
The pharmaceutical industry is increasingly using different sterilisation technologies rather than steam sterilisation. This increase is driven by the need for sterilising thermo-labile products or areas that cannot be dimensioned as a pressure vessel (barrier systems such as Closed Restricted Access Areas or Isolators), under “softer” conditions.
18 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
A policy has been implemented to aid companies in the formulation, production and manufacture of generic drugs, especially when the originals are expensive...
14 February 2019 | By European Pharmaceutical Review
Draft guidance has been released to offer advice on the new CDER program for the recognition of voluntary consensus standards relating to pharma quality...
11 February 2019 | By Particle Measuring Systems
Following the patent of the "Espresso" innovative infusion device, the Italian Biochemical Institute (IBI) "Lorenzini" commissioned Comecer to construct a new isolated filling line.
11 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
The falsified medicines directive (FMD) has finally kicked in, but how will the UK supply chain be affected, and how will pharmacies and hospitals cope?
6 February 2019 | By PQE Group
The counting of votes that saw the election of Mr. Claudio Puglisi, new COO of PQE Group, was held last January 31st in Milan, Italy...
5 February 2019 | By Sciex
Amlodipine is an angioselective calcium channel blocker used to treat high blood pressure, chest pain and other conditions caused by coronary artery disease.
29 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
The role of personalised and precision medicine may be ideal for the treatment of cancer, but questions about consequences and society issues still remain...
29 January 2019 | By AdvantaPure
New from AdvantaPure is AdvantaSil High Pressure unreinforced silicone tubing, a high quality, cost effective solution designed to deliver increased flow rates and reduce processing time...
Follow: